The Drug Enforcement Administration has reversed its decision to the scheduling proposal that would have placed five tryptamine hallucinogens, as identified in this proposed rule, in schedule I of the Controlled Substances Act.

In partnership with the newly founded Center for Psychedelic Drug Research and Education at The Ohio State University, Psychedemia 2022 will provide a rigorous interdisciplinary symposium for exchanging ideas, evaluating dominant perspectives, and critiquing current approaches to developing social frameworks for psychedelic use.

Red Light Holland Corp. based in the Netherlands, is partnering with Rapper Wiz Khalifa to launch MisterCap, A premium brand of magic mushrooms and truffles to the recreational market, along with mushroom-themed merchandise, decor, and tele-counseling services. This collaboration with Wiz Khalifa is to leverage the rapper’s significant social media presence and help grow the brand.

New Jersey Introduced a bill that would legalize the possession, home cultivation, ingesting, and gifting of psilocybin mushrooms for adults 21 and older to promote mental health and wellness

B.C.-based company, Optimi Health has harvested its first cultivation of psilocybin mushrooms at its Health Canada-licensed facilities in Princeton, B.C., positioning itself as a major player in the burgeoning psychedelic sector. According to Optimi's head cultivator, Todd Henderson, The $14-million venture consists of two 10,000-square-feet facilities with a combined total of 10 growing rooms that can produce approximately 2,000 kilograms of dried psilocybin mushrooms a month.

Unlimited Sciences in collaboration with Dr. Robin Carhart-Harris, will conduct an observational research study with a group of primarily female immigrants and refugees who will participate in an Ayahuasca ceremony in the hopes that the experience will help them heal from prior trauma. The study will engage licensed therapists and psychologists who are experienced with psychedelic therapy and Integration

'We Should Take This Seriously”

Elon Musk, Owner of Tesla, SpaceX, Boring Co. Starlink and Solar City, is the world’s richest man and outspoken eccentric innovator of “The Future”, who believes we need to ditch the pills and look at Psychedelics, Hallucinogens, and Entheogens like Mushrooms, LSD, and MDMA as a Serious Treatment for Mental Health and Expanding Human Consciousness.

Awakn Life Sciences Corp. , a psychedelic biotechnology company focused on researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder, has announced on June 2nd that they have initiated a larger behavioral addiction study investigating ketamine as a treatment for Gambling Disorder.

A Maryland House of Delegates Committee recently held a hearing on creating a psychedelics access fund. The Post-Traumatic Stress Disorder and Traumatic Brain Injury Alternative Therapies Fund could give Maryland’s veterans access to psychedelics like psilocybin, MDMA, and ketamine to help them find relief.

Activists staged a demonstration outside of the Drug Enforcement Administration headquarters in Virginia, demanding that the agency allow terminally ill patients to access psilocybin therapy. The Protest was meant to call attention to DEA’s obstruction of Right to Try statutes at the federal and state level that patients and advocates say should facilitate legal use of psychedelics.

THE NATURAL MEDICINE HEALTH ACT OF 2022, Brings Colorado one step closer to Psychedelic Drug Decriminalization

For the first time we find that psilocybin works differently from conventional antidepressants – making the brain more flexible and fluid, and less entrenched in the negative thinking patterns associated with depression

TripSitter Clinic Corp is an international psychedelic medicine and telehealth company enabling physician directed safe and legal entheogen treatment plans. They are currently developing virtual health clinics to help with monitoring, and coaching with patients and licensed physicians. They have recently teamed up in medical, clinical, and administrative operations with Insight Systems, PBC dba Reconscious Medical, which is a psychedelic psychotherapy company engaging in both in-clinic and online virtual care with safety, monitoring, and support provided through a proprietary technology platform.

Today the hot news is that Ecstasy and psilocybin are shaking up psychiatry with psychedelic Therapy Schools Popping Up everywhere like little Magic Mushrooms! In addition to recently announced Hawaii, New Psychedelic Bills are being filed in Florida, Connecticut, Vermont and New Jersey, as the freedom of consciousness and natural medicine movement sweeps the globe.

Despite thousands of years of shamanic psychological clinical trials in the wild, leading to profound revelations of apex love elevations beyond the mind of space and time. Modern scientific research is finally caching up. And we are on the verge of tapping into the extensive healing potential of ENTHEOGENS such as Mother Ayahuasca, DMT, Psilocybin Magic Mushrooms, Sassafras MDMA, LSD, Wily Coyote Peyote and the many other sacred plants recently decriminalized in the great American Cities of Denver, Colorado, Oakland, Santa Cruz California, the Great State of Oregon and the capital itself, Washington DC.

The latest states to join us on our quest for consciousness freedom are Florida and New Jersey, who have taken the next steps in clinical trials of entheogens. Oregon also just officially decriminalized all drugs and replaced jail time with a $100 fine for public possession or intoxication, along with a health assessment for addiction and mental health issues, which seems like a healthier step in the right direction.

Among the first casualties of the psychedelic revolution is MindCure Health (MCURF), which was focused on mental health and wellness. The company’s CEO, Philip Tapley announced they were shutting down operations due to a lack of funding and decided to immediately eliminate all expenditures outside those required to preserve the value of the Company's assets.

Previous studies have shown that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.

In the past 12 months, Cybin has expanded the psychedelic organization to more than 55 employees across four countries and has established partnerships with over 50 participants in the psychedelic industry.

The U.S. Food and Drug Administration has authorized The Peter Thiel-Backed Psychedelics Company German psychedelics startup Atai Life Sciences to conduct a clinical trial on a nonpsychedelic form of ketamine for treatment-resistant depression.